Accession Number : ADA332967
Title : Treatment of Premenstrual Dysphoric Disorder With Sertraline During the Luteal Phase
Descriptive Note : Final rept 1 Dec 94-30 Sep 95
Corporate Author : WALTER REED ARMY MEDICAL CENTER WASHINGTON DC
Personal Author(s) : Hurt, Peyton H.
PDF Url : ADA332967
Report Date : OCT 1995
Pagination or Media Count : 19
Abstract : The authors designed a randomized, double-blind, crossover study to assess the efficacy of Sertraline in the treatment of Premenstrual Dysphoric Disorder (PMDD) when given only during the luteal phase of the menstrual cycle. Thirty-one subjects were selected for a seven month study period.
Descriptors : *MENSTRUATION, THERAPY, DRUGS, PLACEBOS, PHARMACOLOGY, PSYCHOANALEPTIC AGENTS.
Subject Categories : Anatomy and Physiology
Medicine and Medical Research
Distribution Statement : APPROVED FOR PUBLIC RELEASE